Spironolactone is a potassium-sparing diuretic used in the treatment of hypertension, mitral valve endocardiosis, atrial fibrillation and ascites due to chronic hepatitis and congestive heart failure.
Spironolactone is also used to treat potassium deficiency and hyperaldosteronism.
Recommended dose rate in dogs is 2 mg/kg orally once daily.
- Kittleson MD & Bonagura JD (2010) Re: Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med 24(6):1245-1246
- Zhao J et al (2010) Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol 159(8):1584-1594
- Raffan E et al (2009) Ascites is a negative prognostic indicator in chronic hepatitis in dogs. J Vet Intern Med 23(1):63-66
- de Madron E et al (2011) Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. Can Vet J 52(11):1219-1225
- Guyonnet J et al (2010) A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog. J Vet Pharmacol Ther 33(3):260-267